<DOC>
	<DOC>NCT01651598</DOC>
	<brief_summary>In this trial the safety, tolerability, pharmacokinetics and exploratory pharmacodynamics of multiple dose administration of BI 144807 will be investigated in otherwise healthy, controlled asthmatic patients</brief_summary>
	<brief_title>Multiple Rising Dose Study of BI 144807 Powder in Bottle in Mild Asthmatic Patients</brief_title>
	<detailed_description />
	<criteria>Inclusion criteria: 1. mild asthmatic, otherwise healthy subjects (male and female of nonchildbearing potential) Exclusion criteria: 1. Apart from mild asthma any relevant deviation from healthy conditions</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>October 2013</verification_date>
</DOC>